Intrathecal rituximab in immunoglobulin G4-hypertrophic pachymeningitis.
J Neuroimmunol
; 334: 576997, 2019 09 15.
Article
en En
| MEDLINE
| ID: mdl-31254930
ABSTRACT
We describe the case of a 69-year-old man who presented with symptoms of headache and severe vision loss due to G4 immunoglobulin (IgG4) hypertrophic pachymeningitis (HP). The patient was initially responsive to corticotherapy, but vision loss progressed when steroid therapy was first tapered. No improvement was noticed with intravenous rituximab. The patient showed clinical and radiological improvement after intrathecal rituximab, which can be an efficacious alternative treatment option.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Inmunoglobulina G
/
Rituximab
/
Antineoplásicos Inmunológicos
/
Meningitis
Límite:
Aged
/
Humans
/
Male
Idioma:
En
Revista:
J Neuroimmunol
Año:
2019
Tipo del documento:
Article